Tag:
Molecular Insight Pharmaceuticals
Latest Headlines
Latest Headlines
Restructuring rejection forces Molecular Insight to declare bankruptcy
Bondholders have scuttled Molecular Insight Pharmaceuticals's plan to secure in financing from private equity outfit Savitr Capital, forcing the developer to file for Chapter 11 bankruptcy. Savitr
Cash squeeze triggers going-concern alert at Molecular Insight
A troubled Molecular Insight Pharmaceuticals (MIPI) needs to raise more cash to avoid breaching the minimum liquidity requirements tied to senior debt at the company, and that cash squeeze helped
Molecular Insight cuts jobs in realignment
Cambridge, MA-based Molecular Insight Pharmaceuticals announced today that it is cutting nine positions as it seeks to reduce operating costs. The company will take a one-time charge of $200,000 in
